Use of Juice+ food supplements, when initiated in the first trimester and used continuously thereafter, will result in a lower incidence of preeclampsia and pregnancy complications. Study sponsored by National Safety Associates, LLC.
Official Title
Minimising Early Pregnancy Oxidative Stress to Maximise Healthy Pregnancy Outcome: Reducing Preeclampsia and Reproductive Loss With Antioxidant-Rich Tablet Supplementation Initiated in the First Trimester
Conditions
- Preeclampsia
- Pregnancy Loss
Study Type
Observational
Study Design
Case Control, Prospective
Further Details
-
Development of preeclampsia during pregnancy
Secondary Outcome Measures:
-
The observed incidence of preterm labor, premature rupture of membranes, perinatal loss
Biospecimen Retention: Samples Without DNA
Study Start
May 2004
Eligibility & Criteria
Official Title
Minimising Early Pregnancy Oxidative Stress to Maximise Healthy Pregnancy Outcome: Reducing Preeclampsia and Reproductive Loss With Antioxidant-Rich Tablet Supplementation Initiated in the First Trimester
Conditions
- Preeclampsia
- Pregnancy Loss
Study Type
Observational
Study Design
Case Control, Prospective
Further Details
-
Development of preeclampsia during pregnancy
Secondary Outcome Measures:
-
The observed incidence of preterm labor, premature rupture of membranes, perinatal loss
Biospecimen Retention: Samples Without DNA
Study Start
May 2004
Eligibility & Criteria
Eligibility
- Ages Eligible for Study: 18 Years to 44 Years
- Genders Eligible for Study: Female
- Accepts Healthy Volunteers: No
- Sampling Method: Non-Probability Sample
Study Population
Patients cared for in the University of Mississippi Medical Center
Inclusion Criteria:
- Pregnant Patients seen in first trimester with low or high risk pregnancy
Exclusion Criteria:
- Pregnant patients first seen after the first trimester
- Unlikely to continue care in our system
- Unwilling to comply with rigor of taking food supplements throughout gestation
Total Enrolment
600
Contact Details
Please refer to this study by its ClinicalTrials.gov identifier: NCT00583635
Contacts
Contact: James N Martin, Jr, MD 601-984-6719 jnmartin@ob-gyn.umsmed.edu
Locations
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: James N Martin, Jr., MD 601-984-6719 jnmartin@ob-gyn.umsmed.edu
Contact: Pamela Tazik 601-815-5007 ptazik@dor.umsmed.edu
Principal Investigator: James N Martin, Jr, MD
Sponsors and Collaborators
University of Mississippi Medical Center
Investigators
Principal Investigator: James N Martin, Jr., MD University of Mississippi Medical Center
Total Enrolment
600
Contact Details
Please refer to this study by its ClinicalTrials.gov identifier: NCT00583635
Contacts
Contact: James N Martin, Jr, MD 601-984-6719 jnmartin@ob-gyn.umsmed.edu
Locations
United States, Mississippi
University of Mississippi Medical Center Recruiting
Jackson, Mississippi, United States, 39216
Contact: James N Martin, Jr., MD 601-984-6719 jnmartin@ob-gyn.umsmed.edu
Contact: Pamela Tazik 601-815-5007 ptazik@dor.umsmed.edu
Principal Investigator: James N Martin, Jr, MD
Sponsors and Collaborators
University of Mississippi Medical Center
Investigators
Principal Investigator: James N Martin, Jr., MD University of Mississippi Medical Center
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.